Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine plus butorphanol PCIA after laparoscopic total hysterectomy
ChiCTR1800015675Phase 4Recruiting
- Sponsor
- Yantai Yuhuangding Hospital
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and butorphanol in postoperative pain (2 arms), sponsored by Yantai Yuhuangding Hospital. Primary endpoint: Analgesic effect. Started Apr 2018; status: recruiting.
02
Drugs
dexmedetomidinebutorphanol
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR1800015675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015675.